Prevention & lipids

Flag, Identify, Network, Deliver (FIND) Lp(a) Machine Learning Model: Targeted Screening Enrichment of Elevated Lipoprotein(a) in Atherosclerotic Cardiovascular Disease

JACC AdvPublished Light Gradient-Boosting Machine machine learning model (MLM) was trained (90% of data) and tested

Authors' conclusion

One-half of adults with ASCVD flagged by FIND Lp(a) MLM had confirmed elevated Lp(a) ≥125 nmol/L. A 2.2-fold screening enrichment was observed (≥125 nmol/L model); enrichment was greater with ≥150 and ≥200 nmol/L submodels. Early performance indicators support the central role of FIND Lp(a) MLM within the ongoing FIND Lp(a) program.

Study context

Population
Adults with ASCVD in the Family Heart Databaseadults with ASCVD, test data set n = 34,499 · test data set 34,499
Participants
344,987 adults
Exposure
Percentage of adults with confirmed Lp ≥125 nmol/L were compared
  • test data setn = 34,499
  • cohort flagged by modeln = 1,553
Methodological details10% of data, deidentified medical records, Family Heart Database
  • 10% of data
  • Deidentified medical records
  • Family Heart Database

Main finding

As reported in the abstract

Confirmed Lp(a) ≥125 nmol/L
Screening enrichment due to the model
2.2-fold

Observational data: associations, not effects.

Further findings

Screening enrichment, submodels

≥150 nmol/L submodel
2.3 fold
≥200 nmol/L submodel
2.7 fold

Feature group importance (Tree Shapley Additive exPlanations)

Medication use was the most important feature group followed by diagnoses and lipid labs

Original publication

FIND Lp(a) Machine Learning Model: Targeted Screening Enrichment of Elevated Lipoprotein(a) in Atherosclerotic Cardiovascular Disease. JACC Adv. Published 11 August 2026. doi:10.1016/j.jacadv.2026.103114

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.